RESUMO
Botanical dietary supplements produced from hops (Humulus lupulus) containing the chemopreventive compound xanthohumol and phytoestrogen 8-prenylnaringenin are used by women to manage menopausal symptoms. Because of the long half-lives of prenylated hop phenols and reports that they inhibit certain cytochrome P450 enzymes, a botanically authenticated and chemically standardized hop extract was tested for Phase I pharmacokinetic drug interactions. Sixteen peri- and postmenopausal women consumed the hop extract twice daily for 2 weeks, and the pharmacokinetics of tolbutamide, caffeine, dextromethorphan, and alprazolam were evaluated before and after supplementation as probe substrates for the enzymes CYP2C9, CYP1A2, CYP2D6, and CYP3A4/5, respectively. The observed area under the time-concentration curves were unaffected, except for alprazolam which decreased 7.6% (564.6 ± 46.1 h·µg/L pre-hop and 521.9 ± 36.1 h·µg/L post-hop; p-value 0.047), suggesting minor induction of CYP3A4/5. No enzyme inhibition was detected. According to FDA guidelines, this hop dietary supplement caused no clinically relevant pharmacokinetic interactions with respect to CYP2C9, CYP1A2, CYP2D6, or CYP3A4/5. The serum obtained after consumption of the hop extract was analyzed using ultra-high performance liquid chromatography-tandem mass spectrometry to confirm compliance. Abundant Phase II conjugates of the hop prenylated phenols were observed including monoglucuronides and monosulfates as well as previously unreported diglucuronides and sulfate-glucuronic acid diconjugates.
Assuntos
Suplementos Nutricionais/análise , Interações Ervas-Drogas , Humulus/química , Perimenopausa/efeitos dos fármacos , Extratos Vegetais/farmacocinética , Pós-Menopausa/efeitos dos fármacos , Adulto , Idoso , Cafeína/farmacocinética , Sistema Enzimático do Citocromo P-450/genética , Sistema Enzimático do Citocromo P-450/metabolismo , Dextrometorfano/farmacocinética , Feminino , Humanos , Pessoa de Meia-Idade , Perimenopausa/genética , Perimenopausa/metabolismo , Extratos Vegetais/administração & dosagem , Pós-Menopausa/genética , Pós-Menopausa/metabolismo , Tolbutamida/farmacocinéticaRESUMO
BACKGROUND AND OBJECTIVE: Perimenopausal depression is caused by the impaired function of the ovarium before menopause and with a series of symptoms. Electroacupuncture (EA) therapy has been demonstrated to improve clinically depression. However, the mechanism underlying its therapeutic activity remains unknown. This study aimed to investigat the effects of EA treatment on the hippocampal neural proliferation through Wnt signaling pathway. METHODS: Chronic unpredictable mild stress (CUMS) combined with bilateral ovariectomy (OVX) were used to establish a rat model of perimenopausal depression. The open field test (OFT) and sucrose preference test (SPT) were used to assess depression-like behaviors in rats. ELISAs were used to measure estrogen (E2), luteinizing hormone (LH) and gonadotropin-releasing hormone (GnRH) levels in the serum. RT-PCR and Western blot assay were utilized for measuring the mRNA expressions and protein expressions of GSK-3ß/ß-catenin. RESULTS: Four-week EA treatment at three points including "Shenshu" (BL23), "Baihui" (GV20) and "Sanyinjiao" (SP6) simultaneously ameliorated depression-like behaviors in rats with CUMS and OVX, whereas rescued the decreased serum level of E2 and prevented the increased serum levels of GnRH and LH. EA treatment ameliorated CUMS and OVX-induced alterations of glycogen synthase kinase-3ß (GSK-3ß) and ß-catenin mRNA levels, ß-catenin and phosphorylated ß-catenin (p-ß-catenin) protein levels. CONCLUSIONS: The results showed that EA treatment promoted hippocampal neural proliferation in perimenopausal depression rats via activating the Wnt/ß-catenin signaling pathway, indicating that EA may represent an efficacious therapy for perimenopausal depression.
Assuntos
Depressão/terapia , Hipocampo/metabolismo , Neurônios/citologia , Perimenopausa/psicologia , Via de Sinalização Wnt , beta Catenina/metabolismo , Animais , Proliferação de Células , Depressão/etiologia , Depressão/genética , Depressão/metabolismo , Modelos Animais de Doenças , Eletroacupuntura , Feminino , Glicogênio Sintase Quinase 3 beta/genética , Glicogênio Sintase Quinase 3 beta/metabolismo , Hipocampo/fisiopatologia , Humanos , Masculino , Neurônios/metabolismo , Perimenopausa/metabolismo , Ratos , Ratos Sprague-Dawley , beta Catenina/genéticaRESUMO
ETHNOPHARMACOLOGICAL RELEVANCE: Xiaochaihutang (XCHT) is a traditional Chinese medicine prescription for thousand years in China. Our previous researches show that XCHT has antidepressant-like effects in several depression models, but effect and mechanism of XCHT in perimenopausal depression are still vague. AIM OF THE STUDY: To reveal the antidepressant-like effect and mechanism of XCHT in perimenopausal mice. MATERIALS AND METHODS: Perimenopausal depression model is executed by ovariectomy combined with chronic unpredictable mild stress (OVX-CUMS). Tail suspension test (TST), forced swim test (FST), elevated plus-maze (EPM), novelty suppressed feeding (NSF) and locomotor activity are used to assess antidepressant-like effects of XCHT. The Level of estradiol (E2), follicle-stimulating hormone (FSH), gonadotrophin releasing hormone (GnRH), corticosterone (CORT), adrenocorticotrophic hormone (ACTH) and corticotropin releasing hormone (CRH) are evaluated by ELISA. Antidepressant mechanisms of XCHT in OVX-CUMS mice are analyzed by 5-hydroxytryptamine (5-HT), tryptophan hydroxylase 2 (TPH2) and estrogen receptor α and ß (ERα/ß). RESULTS: The results show that OVX-CUMS significantly increases the immobility time in TST and FST, increases latency to feed, decreases food consumption in NSF and both the time spend and number of entries in open arms in EPM. While, oral administration of XCHT can significantly normalize above depression-like behaviors in OVX-CUMS mice. Moreover, XCHT also remarkably normalized levels of 5-HT, 5-HIAA, E2, GnRH, CORT, ACTH and CRH in OVX-CUMS mice. Finally, the expression of ERß and TPH2 are decreased by OVX-CUMS in prefrontal cortex and hypothalamus, and XCHT can restore these decrease. CONCLUSION: Current findings suggest XCHT can alleviate perimenopausal depression-like behaviors, restore 5-HT and hormones in OVX-CUMS mice, which may be related to normalizing the functions of HPA/HPO axis and enhancing expression of ERß and TPH2 in prefrontal cortex and hypothalamus.
Assuntos
Antidepressivos/farmacologia , Comportamento Animal/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Depressão/tratamento farmacológico , Medicamentos de Ervas Chinesas/farmacologia , Perimenopausa/efeitos dos fármacos , Animais , Encéfalo/metabolismo , Encéfalo/fisiopatologia , Depressão/etiologia , Depressão/metabolismo , Depressão/psicologia , Modelos Animais de Doenças , Receptor beta de Estrogênio/metabolismo , Comportamento Alimentar/efeitos dos fármacos , Hormônios/metabolismo , Locomoção/efeitos dos fármacos , Aprendizagem em Labirinto/efeitos dos fármacos , Camundongos , Ovariectomia , Perimenopausa/metabolismo , Perimenopausa/psicologia , Serotonina/metabolismo , Estresse Psicológico/complicações , Triptofano Hidroxilase/metabolismoRESUMO
With aging, there is an increasing risk for women to develop perimenopause syndrome, which is harmful to women's physical and mental health. The present study investigated the health benefits of bilberry anthocyanin (BA) on aging perimenopausal Sprague-Dawley rats. Rats that entered into perimenopause through natural aging were treated for 8 weeks with BA, and received either a low dose (LD, 35 mg per kg of bodyweight), medium dose (MD, 70 mg per kg of bodyweight), or high dose (HD, 140 mg per kg of bodyweight). The experimental results suggested that all three dosages of BA, especially the high dose, significantly reduced the serum total cholesterol (TC), triglyceride (TG) and low density lipoprotein cholesterol (LDL-C) levels. In addition, BA supplementation markedly reduced the serum malondialdehyde (MDA), effectively increased the activity of hepatic total superoxide dismutase (T-SOD), significantly raised the high density lipoprotein cholesterol (HDL-C), increased the number of estrogen receptors, and effectively up-regulated the expression levels of G protein-coupled receptor 30 (GPR30), protein kinase B (AKT), and extracellular regulated protein kinase 2 (ERK2). In summary, BA has a great effect on improving the serum cholesterol in natural aging perimenopausal rats via the estrogen receptor signaling pathway, and it may be used as a dietary supplement for perimenopause women to decrease the risk of cardiovascular disease.
Assuntos
Envelhecimento/efeitos dos fármacos , Antocianinas/administração & dosagem , Perimenopausa/efeitos dos fármacos , Extratos Vegetais/administração & dosagem , Receptores de Estrogênio/metabolismo , Vaccinium myrtillus/química , Envelhecimento/genética , Envelhecimento/metabolismo , Animais , HDL-Colesterol/metabolismo , LDL-Colesterol/metabolismo , Feminino , Humanos , Perimenopausa/genética , Perimenopausa/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores de Estrogênio/genética , Receptores Acoplados a Proteínas G/genética , Receptores Acoplados a Proteínas G/metabolismo , Superóxido Dismutase/genética , Superóxido Dismutase/metabolismo , Triglicerídeos/metabolismoRESUMO
OBJECTIVE: To investigate the efficacy of self-made Gengnian decoction on expressions of phosphatidylinositol 3-kinase (PI3K), protein kinase B (Akt) and mammalian target of rapamycin (mTOR) in ovarian tissues of perimenopausal rats. They were identified with symptom pattern of kidney-Yang deficiency in terms of Traditional Chinese Medicine. METHODS: Female Sprague-Dawley rats aged 10-12 months were selected. Estrous cycle was observed by vaginal smears of keratinocytes to screen the perimenopausal model rats. The chosen rats were randomly divided into five groups, including perimenopausal model of kidney-Yang deficiency group (24 rats), self-made Gengnian decoction of high-dose group (24 rats), self-made Gengnian decoction of middle-dose group (24 rats), self-made Gengnian decoction of low dose group (24 rats) and tibolone control group (24 rats). In addition, rats aged 4-6 months were selected as young control group. The perimenopausal model rats of kidney-Yang deficiency were prepared by alternative intramuscular injection of hydrocortisone 5 mg·kgï¼1·dï¼1 The successfully prepared models in self-made Gengnian decoction of high-dose, middle-dose and low-dose groups and tibolone control group were given self-made Gengnian decoction 26.4, 13.2 and 6.6 mg·kgï¼1·dï¼1, and tibolone tablets solvent 0.22 mg·kgï¼1·dï¼1, respectively, through intragastric administration. Models group and young control group were given the same dose of normal saline, 1 time a day for 15 consecutive days. 24 h after the last administration, blood and ovarian tissues were collected after anesthesia with 20% ethyl carbamate. The follicles of different levels in ovarian tissue were observed and counted by histopathological hematoxylin-eosin staining. Enzyme linked immunosorbent assay was applied to test insulin-like growth factor-1 (IGF-1) level in the serum of experimental rats. The expression levels of PI3K, phosphorylated-Akt (p-Akt) and phosphorylated-mTOR (p-mTOR) mRNA in ovarian tissue were detected by quantitative real-time polymerase chain reaction. RESULTS: The total follicle counts of perimenopausal model rats with kidney-Yang deficiency were significantly reduced, and the number of follicles (mainly increased in preantral follicles and antral follicles) in perimenopausal model rats with kidney-Yang deficiency was significantly increased after intervention of high and middle doses of Gengnian decoction and tibolone (P < 0.05). Compared with normal rats in young control group, the levels of IGF-1 in serum of perimenopausal rats with kidney-Yang deficiency were significantly decreased (P < 0.01), and those intervened by high dose of Gengnian decoction and tibolone were significantly up-regulated. The relative expression levels of PI3K, p-Akt, p-mTOR mRNA in ovarian tissues of perimenopausal rats with kidney-Yang deficiency were significantly lower than those of young rats (P < 0.01), and those intervened by high dose of Gengnian decoction and tibolone were significantly up-regulated (P < 0.05). CONCLUSION: Self-made Gengnian decoction can increase the levels of IGF-1, PI3K, Akt and mTOR mRNA expression in serum.
Assuntos
Perimenopausa/metabolismo , Fosfatidilinositol 3-Quinases/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Serina-Treonina Quinases TOR/metabolismo , Animais , Medicamentos de Ervas Chinesas/uso terapêutico , Ensaio de Imunoadsorção Enzimática , Feminino , Fator de Crescimento Insulin-Like I/metabolismo , Queratinócitos/efeitos dos fármacos , Queratinócitos/metabolismo , Medicina Tradicional Chinesa/métodos , Ovário/metabolismo , Perimenopausa/efeitos dos fármacos , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-DawleyRESUMO
PURPOSE OF REVIEW: Isoflavones exert estrogenic activity distinct from estrogen, they have the potential to treat diseases and symptoms related to estrogen deficiency with minimal side effects and risks. Isoflavone supplementation, in general, is shown to exert beneficial effects against estrogen-deficient bone loss in women, however, some clinical trials still produce conflicting findings. The purpose of this review is to highlight and summarize the most recent and up-to-date research in the field and to bring attention to factors that play a major role in the outcomes of clinical trials that investigate phytoestrogens. Here, we also discuss the latest and most relevant data regarding the clinical safety of these substances. RECENT FINDINGS: Isoflavones are naturally occurring secondary metabolites found in the Fabacaea plant family. Clinical data from isoflavone interventions support that aglycones (abundant in fermented products) exert enhanced beneficial effects against estrogen-deficient bone loss in women compared with isoflavone glycosides. Studies that employ methods to determine isoflavone content and form of treatments are more likely detect beneficial effects on bone. EFSA have confirmed the safety of isoflavones for women in the most comprehensive report to date. SUMMARY: Isoflavone aglycones exert greater effects against bone loss than glycosides. Isoflavones show promise as a first-line prophylactic/treatment for bone loss in women.
Assuntos
Suplementos Nutricionais , Isoflavonas/farmacologia , Perimenopausa/metabolismo , Fitoestrógenos/farmacologia , Pós-Menopausa/metabolismo , Adulto , Osso e Ossos/efeitos dos fármacos , Feminino , Humanos , Pessoa de Meia-IdadeRESUMO
Dehydroepiandrosterone (DHEA) is a widespread nutritional "anti-aging" supplement. Exogenous supplementation of DHEA is now being commonly used to augment ovarian stimulation in perimenopausal women with diminished ovarian reserve. Whether DHEA causes side effects in such age is, however, unknown. Thus, this study investigates the effects of pharmacological doses of DHEA supplementation on the liver of perimenopausal rats. DHEA supplementation to perimenopausal rats resulted in slight hepatomegaly and steatosis, hepatocytic hypertrophy, mitochondrial swelling, elevation in serum alanine aminotransaminase levels, in addition to the accumulation of lipid droplets and lipolysosomes in a dose-dependent manner. In conclusion, long-term administration of high doses of DHEA causes ultrastructural alterations and changes in the levels of cholesterol and triglyceride in hepatocytes of perimenopausal rats. DHEA at a dose of 50 mg/kg improves health and decreases the body weight, with the least side effects on the liver of perimenopausal rats.
Assuntos
Desidroepiandrosterona/farmacologia , Retículo Endoplasmático/ultraestrutura , Fígado/efeitos dos fármacos , Fígado/patologia , Perimenopausa/efeitos dos fármacos , Animais , Peso Corporal/efeitos dos fármacos , Colesterol/metabolismo , Fígado/ultraestrutura , Perimenopausa/metabolismo , RatosRESUMO
BACKGROUND: Dehydroepiandrosterone (DHEA) is a weak androgen and a crucial precursor of sex steroids. Exogenous supplementation of DHEA is now being commonly used to augment ovarian stimulation in women with diminished ovarian reserve. However, the effects of DHEA are controversial. AIMS: This study verifies the effects of pharmacologic doses of DHEA on the ovarian reserve variables, follicular development, reproductive function, and pregnancy outcomes of perimenopausal rats. MAIN METHODS: The reproductive function was studied by monitoring the estrous cycle and hormones. The ovarian reserve was studied by testing the anti-mullerian hormone and ovarian histology. The follicular development was studied histologically and immunohistochemically. KEY FINDINGS: DHEA supplementation at a dose of at 50â¯mg/kg improved the ovarian reserve and pregnancy outcomes. Higher doses of DHEA caused PCOs-like symptoms manifested by the development of cystic follicles and low ovarian reserve and pregnancy outcomes. SIGNIFICANCE: DHEA is a promising treatment that improves the ovarian reserve parameters and pregnancy outcomes. Further studies are needed to determine the optimal dose and duration.
Assuntos
Desidroepiandrosterona/farmacologia , Fertilidade/efeitos dos fármacos , Reserva Ovariana/efeitos dos fármacos , Perimenopausa/efeitos dos fármacos , Resultado da Gravidez , Animais , Desidroepiandrosterona/efeitos adversos , Relação Dose-Resposta a Droga , Feminino , Fertilidade/fisiologia , Masculino , Reserva Ovariana/fisiologia , Perimenopausa/metabolismo , Síndrome do Ovário Policístico/induzido quimicamente , Síndrome do Ovário Policístico/metabolismo , Síndrome do Ovário Policístico/patologia , Gravidez , RatosRESUMO
OBJECTIVE: To observe the effect of electroacupuncture (EA) on the hormones derived from the hypothalamus-pituitary-ovary (HPO) axis, so as to explore the neuroendocrine mechanism induced by EA on rats with perimenopausal depression disorder. METHODS: Sixty female sprague-dawley rats were randomly divided into blank control group, model group, sham-operation (sham) group, clomipramine group, and electroacupuncture (EA) group, with 12 rats in each group. Perimenopausal depression model was established by bilateral ovariectomy combined with chronic unpredictable stimulation.The EA group received continuous treatment at "Baihui" (GV 20), "Shenshu" (BL 23) and "Sanyinjiao" (SP 6) once a day for 28 days. Estrous cycle and sucrose preference test were monitored, and serum estradiol (E2), luteinizing hormone (LH), gonadotropin releasing hormone (GnRH), and ß-endorphin (ß-EP) were detected by ELISA. RESULTS: Compared to the blank control group, sugar water consumpution rates decreased in the model group and sham group (P<0.05). Compared to the blank group and sham group, the serum LH and GnRH levels increased (P<0.05), companied with lower serum E2 and ß-EP levels in the model group (P<0.05). Compared to the model group, sugar water consumpution rates increased in the clomipramine group and EA group (P<0.05), both were companied with decreased serum LH and GnRH levels (P<0.05), and higher serum E2 and ß-EP levels (P<0.05). CONCLUSIONS: Electroacupuncture can relieve the symptoms of rat with perimenopausal depression by regulating the hormone secretion in HPO axis.
Assuntos
Depressão/terapia , Eletroacupuntura , Hipotálamo/metabolismo , Ovário/metabolismo , Perimenopausa/psicologia , Hipófise/metabolismo , Pontos de Acupuntura , Hormônio Adrenocorticotrópico/metabolismo , Animais , Depressão/genética , Depressão/metabolismo , Feminino , Humanos , Hormônio Luteinizante/metabolismo , Perimenopausa/metabolismo , Ratos Sprague-Dawley , beta-Endorfina/metabolismoRESUMO
After advanced age, female sex is the major risk factor for Alzheimer's disease (AD). The biological mechanisms underlying the increased AD risk in women remain largely undetermined. Preclinical studies identified the perimenopause to menopause transition, a neuroendocrine transition state unique to the female, as a sex-specific risk factor for AD. In animals, estrogenic regulation of cerebral glucose metabolism (CMRglc) falters during perimenopause. This is evident in glucose hypometabolism and decline in mitochondrial efficiency which is sustained thereafter. This study bridges basic to clinical science to characterize brain bioenergetics in a cohort of forty-three, 40-60 year-old clinically and cognitively normal women at different endocrine transition stages including premenopause (controls, CNT, n = 15), perimenopause (PERI, n = 14) and postmenopause (MENO, n = 14). All participants received clinical, laboratory and neuropsychological examinations, 18F-fluoro-deoxyglucose (FDG)-Positron Emission Tomography (PET) FDG-PET scans to estimate CMRglc, and platelet mitochondrial cytochrome oxidase (COX) activity measures. Statistical parametric mapping and multiple regression models were used to examine clinical, CMRglc and COX data across groups. As expected, the MENO group was older than PERI and controls. Groups were otherwise comparable for clinical measures and distribution of APOE4 genotype. Both MENO and PERI groups exhibited reduced CMRglc in AD-vulnerable regions which was correlated with decline in mitochondrial COX activity compared to CNT (p's<0.001). A gradient in biomarker abnormalities was most pronounced in MENO, intermediate in PERI, and lowest in CNT (p<0.001). Biomarkers correlated with immediate and delayed memory scores (Pearson's 0.26≤r≤0.32, p≤0.05). These findings validate earlier preclinical findings and indicate emergence of bioenergetic deficits in perimenopausal and postmenopausal women, suggesting that the optimal window of opportunity for therapeutic intervention in women is early in the endocrine aging process.
Assuntos
Envelhecimento/metabolismo , Doença de Alzheimer/metabolismo , Encéfalo/metabolismo , Metabolismo Energético/fisiologia , Perimenopausa/metabolismo , Pós-Menopausa/metabolismo , Adulto , Envelhecimento/patologia , Envelhecimento/psicologia , Doença de Alzheimer/diagnóstico por imagem , Doença de Alzheimer/patologia , Doença de Alzheimer/psicologia , Plaquetas/metabolismo , Plaquetas/patologia , Encéfalo/diagnóstico por imagem , Encéfalo/patologia , Mapeamento Encefálico , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Feminino , Fluordesoxiglucose F18/administração & dosagem , Glucose/metabolismo , Humanos , Memória/fisiologia , Pessoa de Meia-Idade , Mitocôndrias/enzimologia , Mitocôndrias/patologia , Testes Neuropsicológicos , Perimenopausa/psicologia , Fenótipo , Tomografia por Emissão de Pósitrons , Pós-Menopausa/fisiologia , Compostos Radiofarmacêuticos/administração & dosagemRESUMO
OBJECTIVE: We wished to study the impact of Chaihushugan San (CSS) on the behavior of perimenopausal rats with liver-Qi stagnation (LQS) and to investigate the effect of CSS on signal transduction of the Raf/mitogen-activated protein kinase (MEK)/ extracellular signal-regulated kinase (ERK) cascade in the hippocampi of rats induced by immobilization. METHODS: Twenty 52-week-old female rats were divided into two groups by the random number table method: model control group (MCG) and CSS group (CSSG), with 10 rats in each group. Ten-week-old female rats were used as the normal control group (NCG). CSS effects were assessed using rats exposed to immobilization stress by measuring body weight and sucrose consumption, serum hormone levels, and observing performance in the open field test (OFT). Molecular mechanisms were examined by measuring the effect of CSS on expression of Raf1, MEK1/2 and ERK1/2 mRNA in hippocampi using quantitative real-time polymerase chain reaction and by measuring levels of these proteins and related phospho-proteins using Western blotting. RESULTS: Perimenopausal rats with LQS had decreased locomotor activity; reduced sucrose consumption; and increased serum levels of corticotropin releasing hormone (CRH) and corticosterone (CORT). Activation of hippocampal Raf/MEK/ERK cascade was suppressed significantly in the MCG, and activation was increased after 21 days of CSS treatment. CONCLUSION: CSS has significant effects upon relief of the symptoms of LQS in immobilization-induced rats. The mechanism underlying this action might (at least in part) be mediated by reversal of disruption of the Raf/MEK/ERK pathway.
Assuntos
Medicamentos de Ervas Chinesas/administração & dosagem , MAP Quinases Reguladas por Sinal Extracelular/genética , Proteínas Quinases Ativadas por Mitógeno/genética , Perimenopausa/efeitos dos fármacos , Quinases raf/genética , Animais , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Feminino , Hipocampo/efeitos dos fármacos , Hipocampo/enzimologia , Humanos , Imobilização , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Perimenopausa/genética , Perimenopausa/metabolismo , Ratos , Ratos Sprague-Dawley , Transdução de Sinais/efeitos dos fármacos , Estresse Fisiológico/efeitos dos fármacos , Quinases raf/metabolismoRESUMO
OBJECTIVE: To investigate the efficiency of Spanishneedles Herb eye drops in treating perimenopausal xerophthalmia in rabbits. METHOD: Totally 36 rabbits (36 right eyes) were ovariectomized, and 2 months later divided into three groups: the experimental group (group A, n = 12) given Spanishneedles Herb eye drops, the control group (group B, n = 12) given PBS and the model group (group C, n = 12) given no drug. The Schirmer I test (SIT), fluorescent (FL), total tear protein, diastase activity, lactoferrin and lysozyme contents and confocal scanning microscopy were performed at before the treatment and at 1 w, 2 w, 1 mo, 2 mo after the treatment. RESULT: Before the treatment, There was no significant difference in SIT, FL, total tear protein, lysozyme, lactoferrin and amylase activity between two groups. Two months later after the treatment, both the group B and the group A showed differences degrees of changes in SIT, FL, total tear protein, lysozyme, lactoferrin and amylase activity compared with that before the treatment, with statistical differences (P < 0.05); At each time point, both groups revealed statistical differences in SIT, FL, total tear protein, lysozyme, lactoferrin and amylase activity (1 < 0.05). Two months later alter the treatment, densities of basal epithelial cells and inflammatory cells in the group A were (4 122 ±416) cells/mm2 and (339 ± 131) cells/mm2, while that in the group B were (3 343 ± 424) cells/mm2 and (49 ± 17) cells/mm2, with statistical differences between them (P < 0.05). CONCLUSION: Spanishneedles Herb eye drops could effectively treat perimenopausal xerophthalmia in rabbit caused by sex hormones decline.
Assuntos
Asteraceae/química , Medicamentos de Ervas Chinesas/administração & dosagem , Soluções Oftálmicas/administração & dosagem , Xeroftalmia/tratamento farmacológico , Animais , Feminino , Humanos , Perimenopausa/efeitos dos fármacos , Perimenopausa/metabolismo , Coelhos , Lágrimas/metabolismo , Xeroftalmia/metabolismoRESUMO
OBJECTIVE: To observe the effects of electroacupuncture (EA) at "Sanyinjiao"(SP 6) on hypothalamus-pituitary-ovary (HPO) axis in perimenopausal rats so as to study its underlying mechanisms in improving dysfunction of HPO axis. METHODS: Eight female SD rats with an age of 3 months were used as the normal control group, other 16 perimenopausal SD rats with an age of 11-15 months were equally randomized into model group and EA group. The menopause model was confirmed by vaginal smear tests for successive 15 days. EA (2 Hz/100 Hz) was applied to bilateral "Sanyinjiao"(SP 6) for 20 min, once every other day for 30 days. After the treatment, the rats' hypothalamus, pituitary and left ovary tissues were collected for detecting the contents of gonadotropin releasing hormone (GnRH), follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E2) by ELISA. RESULTS: Compared with the normal control group, the ovary E2 content of the model group was significantly decreased (P < 0.01), and the pituitary FSH and LH contents, and hypothalamic GnRH content were obviously increased in the model group (P < 0.01). Following EA intervention, the ovary E2 level was obviously elevated (P < 0.05), while pituitary FSH and LH and hypothalamic GnRH levels were significantly down-regulated in comparison with the model group (P < 0.05). CONCLUSION: EA of "Sanyinjiao" (SP 6) can suppress menopause-induced down-regulation of ovary E2 and increase of pituitary FSH and LH and hypothalamic GnRH levels in perimenopausal rats, suggesting a favorable regulation of EA on HPO axis dysfunction.
Assuntos
Pontos de Acupuntura , Eletroacupuntura , Hipotálamo/metabolismo , Ovário/metabolismo , Perimenopausa/metabolismo , Hipófise/metabolismo , Animais , Estradiol/metabolismo , Feminino , Hormônio Foliculoestimulante/metabolismo , Hormônio Liberador de Gonadotropina/metabolismo , Humanos , Hormônio Luteinizante/metabolismo , Perimenopausa/genética , Ratos , Ratos Sprague-DawleyRESUMO
Human aging is characterized by a marked decrease in circulating levels of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS), hormonal changes associated with cognitive decline. Despite beneficial effects of DHEA supplementation in rodents, studies in elderly humans have generally failed to show cognitive improvement after treatment. In the present study we evaluate the effects of age and estradiol supplementation on expression of genes involved in the de novo synthesis of DHEA and its conversion to estradiol in the rhesus macaque hippocampus. Using reverse transcription polymerase chain reaction (RT-PCR) we demonstrate the expression of genes associated with this synthesis in several areas of the rhesus brain. Furthermore, real-time PCR reveals an age-related attenuation of hippocampal expression level of the genes CYP17A1, STS, and 3BHSD1/2. Additionally, short-term administration of estradiol is associated with decreased expression of CYP17A1, STS, SULT2B1, and AROMATASE, consistent with a downregulation not only of estrogen synthesis from circulating DHEA, but also of de novo DHEA synthesis within the hippocampus. These findings suggest a decline in neurosteroidogenesis may account for the inefficacy of DHEA supplementation in elderly humans, and that central steroidogenesis may be a function of circulating hormones and menopausal status.
Assuntos
Envelhecimento/fisiologia , Desidroepiandrosterona/biossíntese , Perimenopausa/metabolismo , Envelhecimento/sangue , Animais , Biomarcadores/sangue , Biomarcadores/metabolismo , Desidroepiandrosterona/sangue , Estradiol/farmacologia , Feminino , Hipocampo/efeitos dos fármacos , Hipocampo/metabolismo , Hidrocortisona/biossíntese , Hidrocortisona/sangue , Macaca mulatta , Masculino , Perimenopausa/efeitos dos fármacos , PrimatasRESUMO
The literatures are retrieved in the Chinese science and technology periodical database of VIP (1989-2009). The clinical application and its mechanism of perimenopausal syndrome treated with acupuncture and moxibustion are summarized. The summarized literatures indicate that body acupuncture, auricular acupuncture, acupoint catgut embedding and combined therapy are used in acupuncture and moxibustion for treatment of perimeno-pausal syndrome. The research of mechanism includes regulation of nerve-endocrine-immunity net, regulation of free radical metabolism, regulation of blood lipid and bone metabolism. The literatures suggest that acupuncture and moxibustion has definite therapeutic effect on perimenopausal syndrome with advantages of convenience, lower cost and safety.
Assuntos
Terapia por Acupuntura , Perimenopausa/metabolismo , Terapia por Acupuntura/economia , Osso e Ossos/metabolismo , Feminino , Humanos , Metabolismo dos Lipídeos , Moxibustão , Perimenopausa/imunologiaRESUMO
OBJECTIVE: To investigate the effect of one kind of regulating-qi and Nourishing-yin Chinese herbs Zuoguiyin on the expression of rats ovarian vascular endothelial growth factor (VEGF) and secreted protein acidic rich in cysteine (SPARC) during the period of peri-menopause. METHOD: The animal models of perimenopause rats were established by natural aging. Perimenopause rats were treated by intragastric administration (ig) with low (13.78 g x kg(-1)), middle (20.67 g x kg(-1)) and high (31 g x kg(-1)) dose of Zuoguiyin for 8 weeks. Expression of VEGF and SPARC mRNA were detected by RT-PCR. Immunohistochemistry was used to evaluate expression levels of VEGF protein. RESULT: Compared with that in the control group, ovarian expression levels of VEGF mRNA and its protein in rats during peri-menopause increased significantly (P < 0.01). Middle and high dose of Zuoguiyin could both down-regulate the expression of VEGF in ovaries of praesenilis rats, and the difference has statistical significance (P < 0.01). Expression levels of SPARC mRNA in rat ovaries during peri-menopausal period decreased obviously compared to that in the control group (P < 0.01). Middle and high dose of Zuoguiyin could greatly promote ovarian SPARC mRNA expression of praesenilis rats (P < 0.01). CONCLUSION: The abnormal changes of VEGF and SPARC may play an important role in the aging process of ovary. Zuoguiyin, one kind of regulating-qi and Nourishing-yin Chinese herbs, can improve ovarian vascular formation through down-regulating the expression of VEGF meanwhile up-regulating the expression of SPARC. And it may delay aging by this way.
Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Expressão Gênica/efeitos dos fármacos , Osteonectina/genética , Ovário/metabolismo , Perimenopausa/metabolismo , Fator A de Crescimento do Endotélio Vascular/genética , Animais , Feminino , Humanos , Modelos Animais , Osteonectina/metabolismo , Ovário/efeitos dos fármacos , Perimenopausa/efeitos dos fármacos , Ratos , Ratos Wistar , Fator A de Crescimento do Endotélio Vascular/metabolismoRESUMO
The effect of exercise modalities on determinants of sarcopenia, specifically, lean tissue mass, maximal voluntary isometric contraction (MVIC), muscle quality (MQ), and cardiorespiratory fitness (VO(2)peak) over 12 weeks were studied in 42 (45-55 years, 60 days of amenorrhea, with =1 h/week physical activity) perimenopausal females. Subjects were assigned to strength training (super-slow, 20 s tension, ST(ss) = 7; hypertrophy, 2-4 s tension, ST(ht) = 8), endurance training (intermittent, >/=48 h rest, ET(i) = 7; consecutive, 24 h, ET(c) = 9) and autogenic training group (AT = 11). ST and ET met 60 min day(-1), 3 days week(-1) and AT 1 day week(-1). Leg extension, incremental cycling with gas exchange, dual-energy X-ray absorptiometry, and blood analysis were tested. The MANOVA revealed that ST(ss) improved MVIC (P < 0.01) and MQ (P = 0.01). The VO(2)peak also increased significantly in ET group by 28% (ET(i): P = 0.02, ET(c): P = 0.01). A modality-specific effect on strength, MQ, and VO(2)peak in perimenopausal females was duly noted.